Vor Biopharma Stock (NASDAQ: VOR) stock price, news, charts, stock research, profile.
Open | $1.740 |
Close | $1.700 |
Volume / Avg. | 181.018K / 318.710K |
Day Range | 1.650 - 1.740 |
52 Wk Range | 1.620 - 5.700 |
Market Cap | $115.967M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 8.74% |
Days to Cover | 7.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vor Biopharma (NASDAQ: VOR) through any online brokerage.
Other companies in Vor Biopharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Vor Biopharma (NASDAQ: VOR) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 11.00 expecting VOR to rise to within 12 months (a possible 547.06% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Vor Biopharma (NASDAQ: VOR) is $1.7 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Vor Biopharma.
Vor Biopharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Vor Biopharma.
Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.